BioPharma Resources

Drug Trial Radar · NCT07796516

Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis

Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis: A Multicenter, Open-Label, Randomized Controlled Study

Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

420

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

Dec 30, 2027

Study completion Jun 30, 2028

Sponsor

Lead sponsor
Peking University People's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 1, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter, open-label, randomized controlled trial designed to preliminarily evaluate the efficacy and safety of telitacicept in patients with refractory rheumatoid arthritis during a 24-week treatment period followed by a 2-week follow-up period.

Conditions

  • Difficult-to-treat Rheumatoid Arthritis
  • Rheumatoid Arthritis

Interventions

  • Telitacicept 160mgBiological

    Telitacicept 160 mg will be administered subcutaneously once weekly for 24 consecutive weeks.

  • Standard therapyDrug

    Standard therapy includes DMARDs, GCs, and NSAIDs.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ACR20 response rateTime frame: Week 24

Locations

47 sites in 1 country. Site status is shown where the registry gives one.

  • Bethune First Hospital of Jilin University

    Changchun, China · Not yet recruiting

  • Anhui Provincial Hospital

    Hefei, Anhui, China · Not yet recruiting

  • First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China · Not yet recruiting

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Army Characteristic Medical Center

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • Second Affiliated Hospital of Fujian Medical University

    Quanzhou, Fujian, China · Not yet recruiting

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Jiangmen Central Hospital

    Jiangmen, Guangdong, China · Not yet recruiting

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, China · Not yet recruiting

  • First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Not yet recruiting

  • Hainan General Hospital

    Haikou, Hainan, China · Not yet recruiting

  • Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Not yet recruiting

  • First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Not yet recruiting

  • Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Not yet recruiting

  • Huaihe Hospital of Henan University

    Kaifeng, Henan, China · Not yet recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • General Hospital of Central Theater Command of the PLA

    Wuhan, Hubei, China · Not yet recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Wuhan Central Hospital

    Wuhan, Hubei, China · Not yet recruiting

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China · Not yet recruiting

  • Hunan Provincial People's Hospital

    Changsha, Hunan, China · Not yet recruiting

  • First Affiliated Hospital of University of South China

    Hengyang, Hunan, China · Not yet recruiting

  • General Hospital of Hunan University of Medicine

    Huaihua, Hunan, China · Not yet recruiting

  • Nantong First People's Hospital

    Nantong, Jiangsu, China · Not yet recruiting

  • Affiliated Hospital of Yangzhou University

    Yangzhou, Jiangsu, China · Not yet recruiting

  • First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China · Not yet recruiting

  • Jilin Provincial People's Hospital

    Changchun, Jilin, China · Not yet recruiting

  • Dalian University of Technology Affiliated Central Hospital

    Dalian, Liaoning, China · Not yet recruiting

  • General Hospital of Northern Theater Command

    Shenyang, Liaoning, China · Not yet recruiting

  • Shengjing Hospital of China Medical Universit

    Shenyang, Liaoning, China · Not yet recruiting

  • Dongying People's Hospital

    Dongying, Shandong, China · Not yet recruiting

  • Shengli Oilfield Central Hospital

    Dongying, Shandong, China · Not yet recruiting

  • Linyi People's Hospital

    Linyi, Shandong, China · Not yet recruiting

  • Qingdao Branch of Qilu Hospital of Shandong University

    Qingdao, Shandong, China · Not yet recruiting

  • Qingdao Municipal Hospital

    Qingdao, Shandong, China · Not yet recruiting

  • Weifang People's Hospital

    Weifang, Shandong, China · Not yet recruiting

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China · Not yet recruiting

  • Zibo Central Hospital

    Zibo, Shandong, China · Not yet recruiting

  • Shanghai Tongji Hospital

    Shanghai, Shanghai Municipality, China · Not yet recruiting

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.